Anti-Biofilm Compounds Derived from Marine Sponges
Open Access
- 19 October 2011
- journal article
- review article
- Published by MDPI AG in Marine Drugs
- Vol. 9 (10), 2010-2035
- https://doi.org/10.3390/md9102010
Abstract
Bacterial biofilms are surface-attached communities of microorganisms that are protected by an extracellular matrix of biomolecules. In the biofilm state, bacteria are significantly more resistant to external assault, including attack by antibiotics. In their native environment, bacterial biofilms underpin costly biofouling that wreaks havoc on shipping, utilities, and offshore industry. Within a host environment, they are insensitive to antiseptics and basic host immune responses. It is estimated that up to 80% of all microbial infections are biofilm-based. Biofilm infections of indwelling medical devices are of particular concern, since once the device is colonized, infection is almost impossible to eliminate. Given the prominence of biofilms in infectious diseases, there is a notable effort towards developing small, synthetically available molecules that will modulate bacterial biofilm development and maintenance. Here, we highlight the development of small molecules that inhibit and/or disperse bacterial biofilms specifically through non-microbicidal mechanisms. Importantly, we discuss several sets of compounds derived from marine sponges that we are developing in our labs to address the persistent biofilm problem. We will discuss: discovery/synthesis of natural products and their analogues—including our marine sponge-derived compounds and initial adjuvant activity and toxicological screening of our novel anti-biofilm compounds.Keywords
This publication has 127 references indexed in Scilit:
- Distinct Pathogenesis and Host Responses during Infection of C. elegans by P. aeruginosa and S. aureusPLoS Pathogens, 2010
- A high-throughput method for assessing chemical toxicity using a Caenorhabditis elegans reproduction assayToxicology and Applied Pharmacology, 2010
- Synergistic Effects between Conventional Antibiotics and 2-Aminoimidazole-Derived Antibiofilm AgentsAntimicrobial Agents and Chemotherapy, 2010
- A Submarine Journey: The Pyrrole-Imidazole AlkaloidsMarine Drugs, 2009
- Amide Isosteres of Oroidin: Assessment of Antibiofilm Activity and C. elegans ToxicityJournal of Medicinal Chemistry, 2009
- Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficitsNature, 2008
- Caenorhabditis elegans: An Emerging Model in Biomedical and Environmental ToxicologyToxicological Sciences, 2008
- Indole is an inter-species biofilm signal mediated by SdiABMC Microbiology, 2007
- Antifungal Chemical Compounds Identified Using a C. elegans Pathogenicity AssayPLoS Pathogens, 2007
- Identification of novel antimicrobials using a live-animal infection modelProceedings of the National Academy of Sciences of the United States of America, 2006